Biologics Spine Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion byJosh SandbergFebruary 12, 2026
Recon Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology byTim AllenFebruary 12, 2026
Recon Spine Genesys Spine Announces Positive Prospective Study Results for SIros® Lateral SI Joint Fusion System byTim AllenFebruary 6, 2026
Biologics Spine Study Shows NanoFuse® Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone byJosh SandbergJanuary 26, 2026
Spine Pain Physician Study Shows Percutaneous Hydrogel Implant for Chronic Low Back Pain Improves Patients’ Pain and Function byTim AllenJanuary 23, 2026
Spine Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal byJosh SandbergJanuary 7, 2026
Biologics Spine Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft byTim AllenDecember 17, 2025
Recon New Lancet-Published Study Shows AI-Powered Decision Support Tool Improves Decision Quality and Patient Outcomes byTim AllenDecember 10, 2025
Biologics Extremities Top Stories Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion byWill SandbergDecember 2, 2025
Spine Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain byTim AllenDecember 2, 2025
